The purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab
Age: 2 - 17 years
Gender: All
We've found 5 total result s for "Arthritis".
The purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab
Age: 2 - 17 years
Gender: All
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Age: 18 years - 66+
Gender: All
"The purpose of this study is to see if the use of apremilast has an effect on the symptoms and progression of central centrifugal cicatricial alopecia (CCCA). Apremilast is an oral PDE4 inhibitor that has anti-inflammatory properties. It inhibits several substances inv...
Age: 18 years - 66+
Gender: Female
The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque psoriasis, and other all forms of psoriasis (such as plaque psoriasis and psoriatic arthritis occurring together). The registry study will tr...
Age: 18 - 99 years
Gender: All
The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. T...
Age: 18 - 99 years
Gender: All